Collin BurdickinSlalom Daily DosePart 3: Unlocking the Future by Addressing the ChallengesThe final article in our series about the potential of generative AI for R&D in life sciences.Oct 12, 2023Oct 12, 2023
Collin BurdickinSlalom Daily DosePart 2: The Importance of Comprehensive Data Corpuses for AI and GenAI Model DevelopmentGenerative AI in life sciencesOct 11, 2023Oct 11, 2023
Collin BurdickinSlalom Daily DoseIntroduction to Generative AI in Life SciencesHow GenAI can support early drug discovery, personalized medicine, and redefine medical devices, diagnostics, and digital healthSep 12, 2023Sep 12, 2023